Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-25 @ 4:02 AM
NCT ID:
NCT03561402
Eligibility Criteria:
Inclusion Criteria:
* Treatment naive patients with relapsing-remitting multiple sclerosis
* Patients treated previously with one or more previous disease-modifying treatments but with a washout period of at least 4 weeks before starting treatment with teriflunomide.
Exclusion Criteria:
* Acute infections in the preceding 4 weeks
* Vaccination in the previous 2 months
* An active malignancy (except basal cell carcinoma)
* Pregnant or breastfeeding patients
* Communication difficulty, i.e. unable to understand the study
* Vulnerable patients, i.e. unable to provide informed consent or lacking legal freedom, e.g. prisoners
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT03561402
Study Brief:
Protocol Section:
NCT03561402